SGLT2 Inhibitors Linked to Lower Risk for AF in T2D
Original Article: https://www.medscape.com/viewarticle/sglt2-inhibitors-linked-lower-risk-af-t2d-2025a1000fej?form=fpf
Diabetes Drug Shows Unexpected Heart PerkA recent study from Germany found that a medicine, commonly prescribed for people with type 2 diabetes (T2D), called an SGLT2 inhibitor may help lower the risk of developing atrial fibrillation … [Read More]

